Wolverine Trading, LLC Cure Vac N.V. Call Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$3.96 - $6.41 $17,028 - $27,563	4,300 Added 39.09%	15,300 $64,000
Q3 2023 Nov 15, 2023	SELL	$6.5 - $10.77 $34,450 - $57,081	-5,300 Reduced 32.52%	11,000 $75,000
Q2 2023 Aug 23, 2023	SELL	$6.69 - $12.25 $60,210 - $110,250	-9,000 Reduced 35.57%	16,300 $169,000
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $65,714 - $128,750	10,300 Added 68.67%	25,300 $169,000
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $9,200 - $13,600	1,600 Added 11.94%	15,000 $90,000
Q3 2022 Nov 14, 2022	BUY	$7.48 - $15.24 $100,232 - $204,216	13,400 New	13,400 $108,000
Q4 2021 Feb 14, 2022	SELL	$33.72 - $48.22 $711,492 - $1.02 Million	-21,100 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$49.26 - $74.5 $1.04 Million - $1.57 Million	21,100 New	21,100 $1.16 Million

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $499M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.